Forecast

There is no analyst data available for this company.

News Go to news feed

Glanbia raises 2026 forecast after strong first half

Glanbia reported a strong first half with adjusted earnings per share of €0.8124 (+30% currency-adjusted) and revenue of €2.1bn (+7% currency-adjusted). Group EBITDA rose 14.1% currency-adjusted to €275.4m and the EBITDA margin improved to 13.2%. Drivers were strong demand for protein products, price stability at Optimum Nutrition and cost savings; management raised the full-year guidance for adjusted EPS to currency-adjusted growth of 17–20% and increased the transformation savings target to €70m per year by 2027. » More on de.investing.com
Glanbia cuts Tirlán representation and reduces board size

The Tirlán Co-operative Society is reducing its representation on the Glanbia board from two directors to one. John Murphy and Bill Carroll will resign on 4 August 2026; Ger O’Brien will be appointed on 5 August 2026 as a Tirlán‑nominated non‑executive director. After the changes, the board will consist of ten directors (two executive, the chair and seven non‑executive, one of whom is from Tirlán). Glanbia reports no further matters requiring disclosure. » More on de.investing.com
Tirlán sells 12 million Glanbia shares for €257.6 million

The Tirlán Co-operative Society has completed the sale of 12,000,000 ordinary shares in Glanbia for a total of around €257.6 million. 9,671,170 shares were sold to institutional investors via an accelerated bookbuild, and 2,328,830 shares were sold off‑market to Glanbia as part of an approved targeted buyback; the price for both transactions was €21.47 per share. After settlement (expected around 16 June 2026) and the cancellation of the shares acquired by the company, Tirlán will remain the largest shareholder with 31,548,762 ordinary shares; the cancellation will reduce issued ordinary shares to an expected 239,613,665 and will use €50 million of the ongoing €100 million buyback program. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, GLANBIA has already paid 0,26€ in dividends. The last payout was in April.

Financials

In the last quarter, GLANBIA had revenue of 2.04b€ and net profit of 150.71m€

(EUR)	Jun 2026	YoY
Revenue	+2.04b	-
Gross profit	+542.97m	-
Net profit	+150.71m	-
EBITDA	+273.20m	-

Fundamentals

Metric	Value
Market capitalization	+5.52b€
Number of shares	242.51m
52-week high/low	+25,60€ - +13,20€
Dividend yield	+1,87%
Dividends TTM	+0,43€
Beta	0,43
P/E ratio	+26,92
PEG ratio	+0,25
P/B ratio	+3,36
P/S ratio	+1,57

Company profile

Glanbia plc ist ein weltweit tätiges Unternehmen im Bereich der Ernährung. Das Unternehmen produziert und vertreibt Sporternährungs- und Lifestyle-Ernährungsprodukte in verschiedenen Formaten, darunter Pulver, verzehrfertige Riegel und Snacks sowie trinkfertige Getränke über verschiedene Vertriebskanäle wie den Fachhandel, den Online-Handel, Fitnessstudios sowie den Lebensmittel-, Drogerie-, Massen- und Clubhandel. Das Unternehmen beschäftigt sich mit der Herstellung und dem Verkauf von Käse, Milchprodukten und nicht-milchbasierten Ernährungs- und Funktionszutaten sowie Vitamin- und Mineralstoffvormischungen. Darüber hinaus ist das Unternehmen in den Bereichen Finanzierung, Forschung und Entwicklung, Immobilien- und Grundstückshandel, Forderungsmanagement, Management, Immobilienleasing, Unternehmensdienstleistungen und Gewichtsmanagementlösungen tätig. Es betreibt ein Portfolio von Marken, darunter OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass und BODY&FIT. Glanbia plc wurde 1964 gegründet und hat seinen Hauptsitz in Kilkenny, Irland.